<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03566121</url>
  </required_header>
  <id_info>
    <org_study_id>2018/01</org_study_id>
    <nct_id>NCT03566121</nct_id>
  </id_info>
  <brief_title>Prediction of the Severity of Female SUI by Measuring New Static and Dynamic Ultrasound Parameters of the Urethra</brief_title>
  <acronym>PRESIUS</acronym>
  <official_title>Prediction of the Severity of Female SUI by Measuring New Static and Dynamic Ultrasound Parameters of the Urethra</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CMC Ambroise Paré</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>CMC Ambroise Paré</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to evaluate the correlation of the ultrasonic functional length of the&#xD;
      urethra and the incontinence urinary disorder (IUD). The goal is to predict the severity of&#xD;
      the IU by measuring new static and dynamic ultrasound parameters of the urethra.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The urinary incontinence is a disorder which affects 25 to 45% of women. Nowadays, the role&#xD;
      of urethral tissue in IUD is not explored although well viewed in perineal ultrasound. Our&#xD;
      actual knowledge demonstrates that urodynamic ultrasound is reliable to establish the bladder&#xD;
      neck mobility. And the posterior urethral wall mobility was often associated to the stress&#xD;
      urinary incontinence. Two elements appeared to indicate the elasticity of the urethral&#xD;
      environment: functional length urethral variation and urethral closure angle variation during&#xD;
      Valsalva manoeuvres compared to rest. This study aims to evaluate the correlation of the&#xD;
      ultrasonic functional length of the urethra and the incontinence urinary disorder for the&#xD;
      purpose to predict the severity of this syndrome.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 10, 2018</start_date>
  <completion_date type="Actual">July 13, 2020</completion_date>
  <primary_completion_date type="Actual">July 13, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Measurement of ultrasonic urethral length</measure>
    <time_frame>From 3 to 11 days after gynecological consultation</time_frame>
    <description>LT total length LF functional length LE funnel urethral length Measurement of the angle between proximal and distal urethra</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Incontinence, Urinary</condition>
  <arm_group>
    <arm_group_label>Continent women</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Women with ICI-Q=0 Pelvic ultrasound / Urodynamic ultrasound</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Incontinent women</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Women with ICI-Q≥1 Pelvic ultrasound / Urodynamic ultrasound</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Pelvic ultrasound / Urodynamic ultrasound</intervention_name>
    <description>Gynecological consultation: calculating the score ICI-Q Ultrasound consultation: pelvic ultrasound Urodynamic ultrasound during a Valsalva manoeuvers</description>
    <arm_group_label>Continent women</arm_group_label>
    <arm_group_label>Incontinent women</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All patients aged over 18 years addressed to pelvic ultrasound&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant&#xD;
&#xD;
          -  Post-partum (under 6 month of childbirth)&#xD;
&#xD;
          -  Operated for a genitourinary prolapse or/and urinary incontinence&#xD;
&#xD;
          -  Utero vaginal symptomatic prolapse&#xD;
&#xD;
          -  Overactive bladder ± UI by&#xD;
&#xD;
          -  Dysuria&#xD;
&#xD;
          -  Severe deep pelvic endometriosis&#xD;
&#xD;
          -  Respiratory failure (Unable to perform the Valsalva manoeuvres)&#xD;
&#xD;
          -  History of pelvic cancer&#xD;
&#xD;
          -  Unable to understand the information communicated&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Georges BADER, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CMC Hartmann</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CMC Hartmann</name>
      <address>
        <city>Neuilly-sur-Seine</city>
        <zip>92200</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Echographie Obstétricale</name>
      <address>
        <city>Paris</city>
        <zip>75116</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>June 12, 2018</study_first_submitted>
  <study_first_submitted_qc>June 12, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 21, 2018</study_first_posted>
  <last_update_submitted>November 9, 2020</last_update_submitted>
  <last_update_submitted_qc>November 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Incontinence</mesh_term>
    <mesh_term>Enuresis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

